Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6274462rdf:typepubmed:Citationlld:pubmed
pubmed-article:6274462lifeskim:mentionsumls-concept:C0004147lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0018318lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0039629lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0054040lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C1521797lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0009491lld:lifeskim
pubmed-article:6274462lifeskim:mentionsumls-concept:C0599756lld:lifeskim
pubmed-article:6274462pubmed:issue2lld:pubmed
pubmed-article:6274462pubmed:dateCreated1982-3-13lld:pubmed
pubmed-article:6274462pubmed:abstractText1 Effects of (--)-, (+/-)-, and (+)-propranolol, atenolol, guanethidine, bretylium and tetracaine were studied on relaxation responses of rabbit ileum and contractile responses of rabbit pulmonary artery and guinea-pig vas deferens to electrical nerve stimulation (2 to 50 Hz). 2 In the ileum, inhibition by tetracaine 3.3 x 10(-6) M occurred at high frequencies of stimulation, while bretylium 1.2 x 10(-4) M and guanethidine 2 x 10(-5) M inhibited responses at all frequencies, the latter producing greater inhibition at low frequencies. 3 (+/-)-Propranolol 10(-5) M produced a tetracaine-type inhibition after 1 h and a bretylium-pattern after 2 h in the ilea and pulmonary arteries and a transition from bretylium- to guanethidine-pattern in the vas deferens, while atenolol 2 x 10(-5) to 10(-4) M produced guanethidine-type inhibition in all preparations. 4 (--)-, (+/-)-, and (+)-Propranolol 3 x 10(-6) to 3.3 x 10(-5) M were equipotent in the vas deferens and ileum. However, inhibition by (--)-propranolol 3.3 x 10(-5) M persisted in the ileum, while that by the (+)-isomer was partially restored by washing. 5 (--)- or (+)-Propranolol 3.3 x 10(-5) M or atenolol 2 x 10(-5) M did not inhibit relaxation of the ileum after the bath temperature was maintained at 4 degrees C for 2 h during drug application. 6 In conclusion, propranolol and atenolol both have gradually developing guanethidine-like adrenergic neurone blocking actions.lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:languageenglld:pubmed
pubmed-article:6274462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:citationSubsetIMlld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6274462pubmed:statusMEDLINElld:pubmed
pubmed-article:6274462pubmed:monthOctlld:pubmed
pubmed-article:6274462pubmed:issn0007-1188lld:pubmed
pubmed-article:6274462pubmed:authorpubmed-author:KubaJJlld:pubmed
pubmed-article:6274462pubmed:authorpubmed-author:MisuYYlld:pubmed
pubmed-article:6274462pubmed:authorpubmed-author:KaihoMMlld:pubmed
pubmed-article:6274462pubmed:issnTypePrintlld:pubmed
pubmed-article:6274462pubmed:volume74lld:pubmed
pubmed-article:6274462pubmed:ownerNLMlld:pubmed
pubmed-article:6274462pubmed:authorsCompleteYlld:pubmed
pubmed-article:6274462pubmed:pagination365-70lld:pubmed
pubmed-article:6274462pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:meshHeadingpubmed-meshheading:6274462-...lld:pubmed
pubmed-article:6274462pubmed:year1981lld:pubmed
pubmed-article:6274462pubmed:articleTitleComparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.lld:pubmed
pubmed-article:6274462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6274462pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6274462lld:pubmed